Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14657686rdf:typepubmed:Citationlld:pubmed
pubmed-article:14657686lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:14657686lifeskim:mentionsumls-concept:C0022671lld:lifeskim
pubmed-article:14657686lifeskim:mentionsumls-concept:C0021270lld:lifeskim
pubmed-article:14657686lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:14657686lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:14657686lifeskim:mentionsumls-concept:C0450127lld:lifeskim
pubmed-article:14657686lifeskim:mentionsumls-concept:C0020501lld:lifeskim
pubmed-article:14657686lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:14657686lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:14657686lifeskim:mentionsumls-concept:C0439165lld:lifeskim
pubmed-article:14657686lifeskim:mentionsumls-concept:C0521115lld:lifeskim
pubmed-article:14657686pubmed:issue10lld:pubmed
pubmed-article:14657686pubmed:dateCreated2003-12-5lld:pubmed
pubmed-article:14657686pubmed:abstractTextCombined liver-kidney transplantation is the definitive treatment for end-stage renal disease caused by primary hyperoxaluria type I (PH1). The infantile form is characterized by renal failure early in life, advanced systemic oxalosis, and a formidable mortality rate. Although others have reported on overall results of transplantation for PH1 covering a wide age spectrum, none has specifically addressed the high-risk infantile form of the disease.lld:pubmed
pubmed-article:14657686pubmed:languageenglld:pubmed
pubmed-article:14657686pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14657686pubmed:citationSubsetIMlld:pubmed
pubmed-article:14657686pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14657686pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14657686pubmed:statusMEDLINElld:pubmed
pubmed-article:14657686pubmed:monthNovlld:pubmed
pubmed-article:14657686pubmed:issn0041-1337lld:pubmed
pubmed-article:14657686pubmed:authorpubmed-author:EsquivelCarlo...lld:pubmed
pubmed-article:14657686pubmed:authorpubmed-author:FillerGuidoGlld:pubmed
pubmed-article:14657686pubmed:authorpubmed-author:MillanMaria...lld:pubmed
pubmed-article:14657686pubmed:authorpubmed-author:SalvatierraOs...lld:pubmed
pubmed-article:14657686pubmed:authorpubmed-author:CoxKenneth...lld:pubmed
pubmed-article:14657686pubmed:authorpubmed-author:SarwalMinnie...lld:pubmed
pubmed-article:14657686pubmed:authorpubmed-author:BerquistWilli...lld:pubmed
pubmed-article:14657686pubmed:authorpubmed-author:SoSam KSKlld:pubmed
pubmed-article:14657686pubmed:authorpubmed-author:WaymanKaren...lld:pubmed
pubmed-article:14657686pubmed:issnTypePrintlld:pubmed
pubmed-article:14657686pubmed:day27lld:pubmed
pubmed-article:14657686pubmed:volume76lld:pubmed
pubmed-article:14657686pubmed:ownerNLMlld:pubmed
pubmed-article:14657686pubmed:authorsCompleteYlld:pubmed
pubmed-article:14657686pubmed:pagination1458-63lld:pubmed
pubmed-article:14657686pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:meshHeadingpubmed-meshheading:14657686...lld:pubmed
pubmed-article:14657686pubmed:year2003lld:pubmed
pubmed-article:14657686pubmed:articleTitleOne hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience.lld:pubmed
pubmed-article:14657686pubmed:affiliationStanford University School of Medicine, Palo Alto, CA 94304, USA. mmillan@stanford.edulld:pubmed
pubmed-article:14657686pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14657686pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14657686lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14657686lld:pubmed